Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Fluhler

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bioanalysis|December 18, 2013
PK of immunoconjugate anticancer agent CMD-193 in rats: ligand-binding assay approach to determine in vivo immunoconjugate stabilityAzher Hussain, Boris Gorovits, Mauricio Leal, et al.
The AAPS Journal|December 12, 2019
AAPS Workshop Report on ICH M10Brian Booth, Faye Vazvaei, Eric Fluhler, et al.
Journal of Pharmaceutical Sciences|September 24, 2010
Controversy in the allometric application of fixed- versus varying-exponent models: a statistical and mathematical perspectiveHuadong Tang, Azher Hussain, Mauricio Leal, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 25, 2007
Interspecies prediction of human drug clearance based on scaling data from one or two animal speciesHuadong Tang, Azher Hussain, Mauricio Leal, et al.
Bioanalysis|May 1, 2018
Report on the 18th Annual Land O'Lakes Bioanalytical ConferenceErik C Burns, Raj Dhodda, Stephanie Pasas-Farmer, et al.
Bioanalysis|November 19, 2010
10th Annual University of Wisconsin Land O'Lakes Bioanalytical ConferenceJames E DeMuth, Mark E Arnold, Brian P Booth, et al.
The AAPS Journal|August 20, 2014
Repeat analysis and incurred sample reanalysis: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamEric Fluhler, Faye Vazvaei, Puran Singhal, et al.
The AAPS Journal|January 1, 2015
Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidanceBrian Booth, Mark E Arnold, Binodh DeSilva, et al.
Bioanalysis|November 24, 2012
Tissue bioanalysis of biotherapeutics and drug targets to support PK/PDHendrik Neubert, Scott Fountain, Lindsay King, et al.
Clinical and Translational Science|March 26, 2018
Novel Application of the Two-Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of ErtugliflozinSangeeta Raje, Ernesto Callegari, Vaishali Sahasrabudhe, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bioanalysis|December 18, 2013
PK of immunoconjugate anticancer agent CMD-193 in rats: ligand-binding assay approach to determine in vivo immunoconjugate stabilityAzher Hussain, Boris Gorovits, Mauricio Leal, et al.
The AAPS Journal|December 12, 2019
AAPS Workshop Report on ICH M10Brian Booth, Faye Vazvaei, Eric Fluhler, et al.
Journal of Pharmaceutical Sciences|September 24, 2010
Controversy in the allometric application of fixed- versus varying-exponent models: a statistical and mathematical perspectiveHuadong Tang, Azher Hussain, Mauricio Leal, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 25, 2007
Interspecies prediction of human drug clearance based on scaling data from one or two animal speciesHuadong Tang, Azher Hussain, Mauricio Leal, et al.
Bioanalysis|May 1, 2018
Report on the 18th Annual Land O'Lakes Bioanalytical ConferenceErik C Burns, Raj Dhodda, Stephanie Pasas-Farmer, et al.
Bioanalysis|November 19, 2010
10th Annual University of Wisconsin Land O'Lakes Bioanalytical ConferenceJames E DeMuth, Mark E Arnold, Brian P Booth, et al.
The AAPS Journal|August 20, 2014
Repeat analysis and incurred sample reanalysis: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamEric Fluhler, Faye Vazvaei, Puran Singhal, et al.
The AAPS Journal|January 1, 2015
Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidanceBrian Booth, Mark E Arnold, Binodh DeSilva, et al.
Bioanalysis|November 24, 2012
Tissue bioanalysis of biotherapeutics and drug targets to support PK/PDHendrik Neubert, Scott Fountain, Lindsay King, et al.
Clinical and Translational Science|March 26, 2018
Novel Application of the Two-Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of ErtugliflozinSangeeta Raje, Ernesto Callegari, Vaishali Sahasrabudhe, et al.
Pageof 2